Media Coverage
International media on the rise of medical travel to China — cutting-edge therapies, world-class hospitals, and a fraction of Western costs. Click any story to read it at the original publisher.
Global Times · Oct 28, 2026
China's innovative anti-cancer drugs highlighted at global oncology event
At the ESMO Congress 2026 in Madrid, 29 studies involving Chinese innovative drugs were selected as late-breaking abstracts — one-third of the conference total — with five featured in the Presidential Symposia, underscoring China's rising strength in pharmaceutical innovation.
Read the article →
Stuff · Oct 15, 2026
Given months to live, a businessman looked overseas for treatment. Now he's cancer free
Auckland businessman Dale De Penning was told he was out of treatment options for his lymphoma, but after receiving CAR T-cell therapy in Shanghai, China, he is now in complete remission — part of Stuff's investigation into New Zealanders travelling overseas for the revolutionary treatment.
Read the article →
People · Sep 22, 2026
Calif. Couple Travels to China for Lifesaving Cancer Treatment: ‘There Was No Hope’
Larry Black and his wife travelled to Shenzhen for satri-cel, a CAR-T therapy for solid tumours approved in China but not yet in the United States, after his stage 3 oesophageal cancer spread.
Read the article →
Futurism · Sep 13, 2026
America’s Health Care System Is So Screwed That Patients Are Flying to China for Cancer Treatment
Futurism reports that Shanghai is emerging as a destination for CAR-T treatment, with Chinese providers offering faster access at about US$150,000–230,000 versus US$550,000–850,000 in the United States.
Read the article →
Global Times · Sep 2026
From spinal implant to cancer therapy, foreign patients seek out China's medical advances
Major Chinese hospitals recorded about 1.28 million international patient visits in 2025, up 73.6% in three years — drawn by breakthroughs such as a spinal cord neural interface and the world's first approved CAR-T therapy for solid tumours.
Read the article →
Inside Precision Medicine · Jun 23, 2026
Solid Tumor CAR-T Therapy Approved in China, a World First
China's NMPA approved CARsgen's satri-cel — the first CAR-T therapy globally approved for a solid tumour — for CLDN18.2-positive advanced gastric cancer, backed by a randomized study published in The Lancet.
Read the article →
Tourism Review · Jan 2026
China's health tourism market is booming
China's wellness and medical travel market is projected to grow from US$25.6bn to US$74.6bn by 2030, backed by "Healthy China 2030" policy and pilot medical tourism zones.
Read the article →
Global Times · Jul 2025
China's booming medical tourism combines advanced care, efficient service and cultural experiences
International patients are travelling to China for advanced treatment, short waiting times and efficient hospital service — combined with travel and cultural experiences.
Read the article →
The Economist · Feb 2026
Why more foreigners are seeking health care in China
Advanced therapies, short waiting times and prices far below Western levels are drawing international patients to Chinese hospitals.
Read the article →
The Straits Times · Jun 2026
Why hospitals in China are attracting more foreign patients
International departments, English-speaking coordinators and faster access to novel treatments are reshaping regional patient flows.
Read the article →
Bloomberg · Jun 2026
China lures foreign patients with cutting-edge, cheap medical care
A feature on China's medical tourism boom, from cell therapy to proton centres, and the patients flying in for it.
Read the article →
CNN Business · Jul 2026
How trips to Asia are making some Americans healthy again
Americans priced out of domestic care are flying to Asia for screenings, dental work and complex treatment.
Read the article →
Yicai Global · 2026
Faster, cheaper access is turning China into a CAR-T therapy hub
China now runs the world's largest number of CAR-T trials, with treatment costs a fraction of US list prices.
Read the article →
Sixth Tone · 2026
As services expand, more foreigners seek treatment in China
Hospitals are building dedicated international services as overseas demand grows across specialties.
Read the article →
The Business Times · Jun 2026
China's nascent medical tourism lures foreign patients
Policy support and new visa channels are accelerating inbound medical travel to mainland China.
Read the article →
CGTN · Jun 2026
From hope to reality: Hainan opens doors to advanced care for all
Hainan's Lecheng pilot zone gives patients early access to drugs and devices approved overseas.
Read the article →Free Case Feasibility Assessment
Start your medical journey to China
Based in Hong Kong and serving international patients, Privilege Medical bridges you to leading Class 3A and JCI-accredited hospitals in mainland China. We do not provide medical care directly — we coordinate specialist matching, medical visa support and on-the-ground concierge from your first enquiry to post-treatment follow-up.
Complete the form below. Our coordination team responds within 1–2 business days with a complimentary assessment covering clinical feasibility, specialist matching and an indicative admission timeline.
Privacy Notice
Privilege Medical is a Hong Kong–based medical concierge and does not provide clinical care. Personal data and medical information you submit are collected, held and used strictly for the purposes of case assessment, specialist matching and coordination of medical services in mainland China, in accordance with the Personal Data (Privacy) Ordinance (Cap. 486) of Hong Kong.
Your data may be transferred to our partner hospitals, treating clinicians and authorised service providers (including translators and travel coordinators), some of whom are located outside Hong Kong. We take reasonable steps to keep your information confidential and secure, and we do not sell your data to any third party.
You have the right, under the PDPO, to request access to and correction of the personal data we hold about you, and to withdraw consent at any time by writing to service@privilegemedical.com. Information submitted via this form is not encrypted end-to-end; please avoid including highly sensitive identifiers (e.g. ID numbers) in the free-text fields.